Clinical relevance of increased serum preneoplastic antigen in hepatitis C-related hepatocellular carcinoma

doi:10.3748/wjg.v26.i13.1463

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 26, Issue 13

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6577)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

449

WORD

209

HTML

2969

Figures (1-3)

233

Tables (1-4)

263

Sum=4123

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

852

Download

1602

Sum=2454

Apr 7, 2020 (publication date) through Jul 25, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical and Translational Research

World J Gastroenterol. Apr 7, 2020; 26(13): 1463-1473
Published online Apr 7, 2020. doi: 10.3748/wjg.v26.i13.1463

Full Size Figure Download Figure

Figure 1 Serum preneoplastic antigen concentrations in controls and in patients with hepatitis C virus-related hepatitis, cirrhosis, or hepatocellular carcinoma. Serum preneoplastic antigen concentrations were measured by ELISA. The results from each patient are plotted, and the means are shown by horizontal bars. The differences between groups were evaluated by Mann-Whitney U tests. The mean with SD and P value for comparison are summarized in the table. n = 89 in control, 50 in hepatitis, 44 in cirrhosis, and 47 in hepatocellular carcinoma.

Citation: Yamashita S, Kato A, Akatsuka T, Sawada T, Asai T, Koyama N, Okita K. Clinical relevance of increased serum preneoplastic antigen in hepatitis C-related hepatocellular carcinoma. World J Gastroenterol 2020; 26(13): 1463-1473
URL: https://www.wjgnet.com/1007-9327/full/v26/i13/1463.htm
DOI: https://dx.doi.org/10.3748/wjg.v26.i13.1463